Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Naloxone Hydrochloride

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Naloxone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 10,350Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Padagis extends Naloxone HCl Nasal Spray shelf-life to 36 months
    Padagis extends Naloxone HCl Nasal Spray shelf-life to 36 months

    02 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/padagis-extends-the-shelf-life-of-naloxone-hci-nasal-spray-4-mg-to-36-months-302418811.html

    PR NEWSWIRE
    02 Apr 2025
    Share Share
    Hikma gets Health Canada approval for Kloxxado Nasal Spray 8 mg
    Hikma gets Health Canada approval for Kloxxado Nasal Spray 8 mg

    20 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/20/3046184/33240/en/Hikma-announces-Health-Canada-approval-of-KLOXXADO-naloxone-HCl-Nasal-Spray-8-mg.html

    GLOBENEWSWIRE
    20 Mar 2025
    Share Share
    Polyrizon Starts Preclinical Studies for Intranasal Naloxone
    Polyrizon Starts Preclinical Studies for Intranasal Naloxone

    13 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/13/3042105/0/en/Polyrizon-Launches-Preclinical-Studies-for-Intranasal-Naloxone-to-Combat-Opioid-Overdose-Using-Cutting-Edge-Platform.html

    GLOBENEWSWIRE
    13 Mar 2025
    Share Share
    Polyrizon Starts Preclinical Studies For Intranasal Naloxone
    Polyrizon Starts Preclinical Studies For Intranasal Naloxone

    10 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/10/3039648/0/en/Polyrizon-Initiates-Preclinical-Studies-for-Intranasal-Naloxone-Targeting-Opioid-Overdose-Based-on-Its-Innovative-T-T-Platform.html

    GLOBENEWSWIRE
    10 Mar 2025
    Share Share
    Scienture, Kindeva To Launch REZENOPY For Opioid Overdose
    Scienture, Kindeva To Launch REZENOPY For Opioid Overdose

    06 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/06/3038102/0/en/SCIENTURE-to-commercially-launch-REZENOPY-a-life-saving-opioid-overdose-emergency-treatment-through-a-collaboration-with-KINDEVA-DRUG-DELIVERY-L-P.html

    GLOBENEWSWIRE
    06 Mar 2025
    Share Share
    Padagis Naloxone Becomes Lowest Priced Treatment on Amazon
    Padagis Naloxone Becomes Lowest Priced Treatment on Amazon

    03 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/padagis-naloxone-now-the-lowest-priced-opioid-overdose-treatment-available-on-amazon-302366429.html

    PR NEWSWIRE
    03 Feb 2025
    Share Share